Nephro Care India Board of Directors
Get the latest insights into the leadership at Nephro Care India. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Sougata Sengupta | Company Secretary & Compliance Officer |
| Pratim Sengupta | Managing Director & CEO |
| Sutapa Sen | Non Executive Director |
| Pritam Sengupta | Non Executive Director |
| Debashish Ghoshal | Non Executive Independent Director |
| Sandeep Shridhar Ghate | Non Executive Independent Director |
| Saikat Biswas | Non Executive Independent Director |
| Sudip Barman | Non Executive Independent Director |
| Alo Sengupta | Non Executive Independent Director |
Nephro Care India FAQs
The board at Nephro Care India consists of experienced professionals, including Sougata Sengupta, Pratim Sengupta, and others, overseeing the company’s strategic and corporate governance.
Directors at Nephro Care India are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Sougata Sengupta is the current chairman at Nephro Care India.
Executive directors at Nephro Care India are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Nephro Care India adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Nephro Care India, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
